Stock 2157 LEPU BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Lepu Biopharma Co., Ltd.

Equities

2157

CNE100004SM4

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 am EDT 		5-day change 1st Jan Change
5.04 HKD +7.23% Intraday chart for Lepu Biopharma Co., Ltd. +16.94% +19.71%
Apr. 12 Keymed Biosciences Advances Solid Tumors Drug With First Patient Study MT
Mar. 27 Lepu Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 10,772 7,742 7,742 -
Enterprise Value (EV) 1 10,786 6,350 8,896 9,274
P/E ratio - - - -
Yield - - - -
Capitalization / Revenue 692 x 28.2 x 39.6 x 28 x
EV / Revenue 693 x 28.2 x 45.6 x 33.5 x
EV / EBITDA -19.4 x -22 x -21.2 x -23.7 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book 12 x 16.7 x -77.8 x -13.3 x
Nbr of stocks (in thousands) 1,659,445 1,659,445 1,659,445 -
Reference price 2 6.491 4.665 4.665 4.665
Announcement Date 3/17/23 3/27/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 15.57 225.4 195.3 276.5
EBITDA 1 -555.9 -288.4 -418.8 -390.8
EBIT 1 -704.5 -391 -568 -548.6
Operating Margin -4,524.03% -173.48% -290.82% -198.45%
Earnings before Tax (EBT) - - - -
Net income - - - -
Net margin - - - -
EPS - - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share 2 - - - -
Announcement Date 3/17/23 3/27/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt 1 14.2 720 1,154 1,532
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) -0.0255 x -2.477 x -2.756 x -3.92 x
Free Cash Flow - - - -
ROE (net income / shareholders' equity) -79.3% -65% - -
ROA (Net income/ Total Assets) - - - -
Assets - - - -
Book Value Per Share 2 0.5400 0.2800 -0.0600 -0.3500
Cash Flow per Share - - - -
Capex - - - -
Capex / Sales - - - -
Announcement Date 3/17/23 3/27/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Lepu Biopharma Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.665 CNY
Average target price
3.403 CNY
Spread / Average Target
-27.06%
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
LEPU BIOPHARMA CO., LTD. Stock Lepu Biopharma Co., Ltd.
+19.71% 1.07B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 2157 Stock
  4. Financials Lepu Biopharma Co., Ltd.